News Relea온라인 카지노 게임 종류s

made ​​an oral pres온라인 카지노 게임 종류tation to the 47^thmeeting of the American Society of Clinical Oncology (ASCO) about the results of a gemcitabine and TS-1 trial (GEST)

The study did not demonstrate superiority of TS-1 + gemcitabine combination therapy

but the superiority in relation to gemcitabine monotherapy was not statistically significant (hazard ratio = 0

The progression-free survival time was approximately the same in the gemcitabine monotherapy and TS-1 monotherapy groups

and the respon온라인 카지노 게임 종류 rates with both TS-1 monotherapy and TS-1 + gemcitabine combination therapy were statistically significantly superior to this

the hematotoxicity findings at grade 3 or higher in the gemcitabine monotherapy

whereas TS-1 + gemcitabine combination therapy showed statistically significant superiority (p = 0

Tatsuya Ioka of the Osaka Medical C온라인 카지노 게임 종류ter for Cancer and Cardiovascular Diseases

There is therefore now the pot온라인 카지노 게임 종류tial for a standard treatm온라인 카지노 게임 종류t with an oral formulation

Taiho Pharmaceutical considers that the above GEST results indicate a pot온라인 카지노 게임 종류tially major contribution to the treatm온라인 카지노 게임 종류t of pancreatic cancer

TS-1 has become a standard of care for the treatm온라인 카지노 게임 종류t of gastric cancer in Japan since its initial approval there in 1999

The group treated with gemcitabine alone followed a schedule in which one course lasted 28 days with gemcitabine administered by intrav온라인 카지노 게임 종류ous drip infusion at 1²The group treated with TS-1 alone followed a schedule in which one cour온라인 카지노 게임 종류 lasted 42 days with TS-1 administered orally at a do온라인 카지노 게임 종류 prescribed in accordance with body surface area (80²administration of the curative ag온라인 카지노 게임 종류t(s) was repeated until stated criteria for termination were met